Tapewire

Nasdaq · USD

KMB

KIMBERLY CLARK CORP

Export transactions ↓
Tapewire entity
3103
SEC CIK
0000055785
Parsed reports
718

Last 12 months

Inside the activity.

1 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202611
Mar 202600
Apr 202601
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 04, 2017 Filed Apr 7, 2017 01:18 UTC GrantRestricted Share Units · Derivative 293.2221 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-007764 · doc4.xml · derivative · entry 1

DECHERD ROBERT W · CIK 0000903649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,262.1064

Underlying: Common Stock · 293.2221 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
April 04, 2017 Filed Apr 7, 2017 01:18 UTC GrantRestricted Share Units · Derivative 268.8052 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-007762 · doc4.xml · derivative · entry 1

BERGSTROM JOHN F · CIK 0001196937 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,909.4353

Underlying: Common Stock · 268.8052 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
February 28, 2017 Filed Jan 5, 2018 18:38 UTC
FALK THOMAS JDirector · Chairman of the Board and CEO
GiftCommon Stock 40,658 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000783 · doc5.xml · nonDerivative · entry 2

FALK THOMAS J · CIK 0001222890 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by TKM II, Ltd.

Disclosed balance after: 599,956

F1 · kind: The reporting person transferred shares of the issuer's common stock to TKM II, Ltd.

F2 · ownership.nature: TKM II, Ltd. is a family limited partnership which is owned by (i) an entity owned by a Trust, controlled by the reporting person and his spouse as general partner, and (ii) a Trust controlled by the reporting person and his spouse as limited partners.

Read SEC document
February 28, 2017 Filed Jan 5, 2018 18:38 UTC
FALK THOMAS JDirector · Chairman of the Board and CEO
GiftCommon Stock 40,658 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000783 · doc5.xml · nonDerivative · entry 1

FALK THOMAS J · CIK 0001222890 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reporting person transferred shares of the issuer's common stock to TKM II, Ltd.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
Mielke Thomas J.SVP - General Counsel
Tax withholdingCommon Stock 4,408 $133.66 $589,173.28
Disclosure

SEC source: 0001225208-17-004989 · doc4.xml · nonDerivative · entry 2

Mielke Thomas J. · CIK 0001412476 · SVP - General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,242.7263

F2 · kind: This transaction represents the automatic surrender of shares to the issuer upon vesting of performance-based restricted shares units to satisfy the reporting person's tax withholding obligations.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
Mielke Thomas J.SVP - General Counsel
GrantCommon Stock 10,506 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-004989 · doc4.xml · nonDerivative · entry 1

Mielke Thomas J. · CIK 0001412476 · SVP - General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,650.7263

F1 · acquired: Represents performance-based restricted share units that have vested and are paid out in shares of common stock.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:52 UTC
Underhill Kimberly KPresident, KCP
Tax withholdingCommon Stock 3,732 $133.66 $498,819.12
Disclosure

SEC source: 0001225208-17-004984 · doc4.xml · nonDerivative · entry 2

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,838

F2 · kind: This transaction represents the automatic surrender of shares to the issuer upon vesting of performance-based restricted shares units to satisfy the reporting person's tax withholding obligations.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:52 UTC
Underhill Kimberly KPresident, KCP
GrantCommon Stock 7,783 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-004984 · doc4.xml · nonDerivative · entry 1

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,570

F1 · acquired: Represents performance-based restricted share units that have vested and are paid out in shares of common stock.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
Hsu Michael D.Director · President & COO
Tax withholdingCommon Stock 6,530 $133.66 $872,799.80
Disclosure

SEC source: 0001225208-17-004988 · doc4.xml · nonDerivative · entry 2

Hsu Michael D. · CIK 0001554339 · Director · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,887

F2 · kind: This transaction represents the automatic surrender of shares to the issuer upon vesting of performance-based restricted shares units to satisfy the reporting person's tax withholding obligations.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
Hsu Michael D.Director · President & COO
GrantCommon Stock 15,565 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-004988 · doc4.xml · nonDerivative · entry 1

Hsu Michael D. · CIK 0001554339 · Director · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,417

F1 · acquired: Represents performance-based restricted share units that have vested and are paid out in shares of common stock.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
Azbell Michael T.Vice President and Controller
Tax withholdingCommon Stock 1,633 $133.66 $218,266.78
Disclosure

SEC source: 0001225208-17-004987 · doc4.xml · nonDerivative · entry 2

Azbell Michael T. · CIK 0001473231 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,567

F2 · kind: This transaction represents the automatic surrender of shares to the issuer upon vesting of performance-based restricted shares units to satisfy the reporting person's tax withholding obligations.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
Azbell Michael T.Vice President and Controller
GrantCommon Stock 3,891 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-004987 · doc4.xml · nonDerivative · entry 1

Azbell Michael T. · CIK 0001473231 · Vice President and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,200

F1 · acquired: Represents performance-based restricted share units that have vested and are paid out in shares of common stock.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
PALMER ANTHONY J.Pres Global Brands & Inno
Tax withholdingCommon Stock 4,571 $133.66 $610,959.86
Disclosure

SEC source: 0001225208-17-004986 · doc4.xml · nonDerivative · entry 2

PALMER ANTHONY J. · CIK 0001430476 · Pres Global Brands & Inno

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,324

F2 · kind: This transaction represents the automatic surrender of shares to the issuer upon vesting of performance-based restricted shares units to satisfy the reporting person's tax withholding obligations.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:53 UTC
PALMER ANTHONY J.Pres Global Brands & Inno
GrantCommon Stock 10,895 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-004986 · doc4.xml · nonDerivative · entry 1

PALMER ANTHONY J. · CIK 0001430476 · Pres Global Brands & Inno

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,895

F1 · acquired: Represents performance-based restricted share units that have vested and are paid out in shares of common stock.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:52 UTC
FALK THOMAS JDirector · Chairman of the Board and CEO
Tax withholdingCommon Stock 29,383 $133.66 $3,927,331.78
Disclosure

SEC source: 0001225208-17-004985 · doc4.xml · nonDerivative · entry 2

FALK THOMAS J · CIK 0001222890 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,658

F2 · kind: This transaction represents the automatic surrender of shares to the issuer upon vesting of performance-based restricted shares units to satisfy the reporting person's tax withholding obligations.

Read SEC document
February 25, 2017 Filed Feb 28, 2017 23:52 UTC
FALK THOMAS JDirector · Chairman of the Board and CEO
GrantCommon Stock 70,041 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-004985 · doc4.xml · nonDerivative · entry 1

FALK THOMAS J · CIK 0001222890 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,041

F1 · acquired: Represents performance-based restricted share units that have vested and are paid out in shares of common stock.

Read SEC document
February 23, 2017 Filed Apr 7, 2017 00:20 UTC
Cruz SergioPresident, Latin America
Exercise / conversionStock Option (Right to Buy) · Derivative 4,045 $0.00 Strike: $107.51 $0.00
Disclosure

SEC source: 0001225208-17-007745 · doc4.xml · derivative · entry 6

Cruz Sergio · CIK 0001696986 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,699

Underlying: Common Stock · 4,045 shares

Expires 2024-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F5 · derivative.exercise_price: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F5 · shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F6 · derivative.exercise_date: The option vests in three annual installments of 30%, 30% and 40%, beginning on April 30, 2015.

F5 · balance_after: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

Read SEC document
February 23, 2017 Filed Apr 7, 2017 00:20 UTC
Cruz SergioPresident, Latin America
Exercise / conversionStock Option (Right to Buy) · Derivative 2,167 $0.00 Strike: $110.72 $0.00
Disclosure

SEC source: 0001225208-17-007745 · doc4.xml · derivative · entry 5

Cruz Sergio · CIK 0001696986 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,058

Underlying: Common Stock · 2,167 shares

Expires 2025-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F4 · derivative.exercise_date: The option vests in three annual installments of 30%, 30% and 40%, beginning on April 29, 2016.

Read SEC document
February 23, 2017 Filed Apr 7, 2017 00:20 UTC
Cruz SergioPresident, Latin America
SaleCommon Stock 6,212 $134.39 $834,830.68
Disclosure

SEC source: 0001225208-17-007745 · doc4.xml · nonDerivative · entry 4

Cruz Sergio · CIK 0001696986 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: This transaction was executed in multiple trades at prices ranging from $134.39 to $134.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 23, 2017 Filed Apr 7, 2017 00:20 UTC
Cruz SergioPresident, Latin America
SaleCommon Stock 4,601 $134.24 $617,638.24
Disclosure

SEC source: 0001225208-17-007745 · doc4.xml · nonDerivative · entry 3

Cruz Sergio · CIK 0001696986 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,212

F1 · price: This transaction was executed in multiple trades at prices ranging from $134.21 to $134.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 23, 2017 Filed Apr 7, 2017 00:20 UTC
Cruz SergioPresident, Latin America
Exercise / conversionCommon Stock 2,167 $110.72 $239,930.24
Disclosure

SEC source: 0001225208-17-007745 · doc4.xml · nonDerivative · entry 2

Cruz Sergio · CIK 0001696986 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,813

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2017 Filed Apr 7, 2017 00:20 UTC
Cruz SergioPresident, Latin America
Exercise / conversionCommon Stock 4,045 $107.51 $434,859.34
Disclosure

SEC source: 0001225208-17-007745 · doc4.xml · nonDerivative · entry 1

Cruz Sergio · CIK 0001696986 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 21, 2017 Filed Feb 23, 2017 21:38 UTC
Underhill Kimberly KPresident, KCP
Exercise / conversionStock Option (Right to Buy) · Derivative 13,951 $0.00 Strike: $107.51 $0.00
Disclosure

SEC source: 0001225208-17-004374 · doc4.xml · derivative · entry 6

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,303

Underlying: Common Stock · 13,951 shares

Expires 2024-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F4 · derivative.exercise_price: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F4 · shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F6 · derivative.exercise_date: The option vests in three annual installments of 30%, 30% and 40%, beginning on April 30, 2015.

F4 · balance_after: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

Read SEC document
February 21, 2017 Filed Feb 23, 2017 21:38 UTC
Underhill Kimberly KPresident, KCP
Exercise / conversionStock Option (Right to Buy) · Derivative 7,789 $0.00 Strike: $110.72 $0.00
Disclosure

SEC source: 0001225208-17-004374 · doc4.xml · derivative · entry 5

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,177

Underlying: Common Stock · 7,789 shares

Expires 2025-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F4 · derivative.exercise_price: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F4 · shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F5 · derivative.exercise_date: The option vests in three annual installments of 30%, 30% and 40%, beginning on April 29, 2016.

F4 · balance_after: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

Read SEC document
February 21, 2017 Filed Feb 23, 2017 21:38 UTC
Underhill Kimberly KPresident, KCP
SaleCommon Stock 21,740 $132.04 $2,870,549.60
Disclosure

SEC source: 0001225208-17-004374 · doc4.xml · nonDerivative · entry 3

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,787

F1 · price: This transaction was executed in multiple trades at prices ranging from $132.00 to $132.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 21, 2017 Filed Feb 23, 2017 21:38 UTC
Underhill Kimberly KPresident, KCP
Exercise / conversionCommon Stock 7,789 $110.72 $862,398.08
Disclosure

SEC source: 0001225208-17-004374 · doc4.xml · nonDerivative · entry 2

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 21, 2017 Filed Feb 23, 2017 21:38 UTC
Underhill Kimberly KPresident, KCP
Exercise / conversionCommon Stock 13,951 $107.51 $1,499,807.84
Disclosure

SEC source: 0001225208-17-004374 · doc4.xml · nonDerivative · entry 1

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:46 UTC
PALMER ANTHONY J.Pres Global Brands & Inno
Exercise / conversionStock Option (Right to Buy) · Derivative 30,325 $0.00 Strike: $98.92 $0.00
Disclosure

SEC source: 0001225208-17-004176 · doc4.xml · derivative · entry 4

PALMER ANTHONY J. · CIK 0001430476 · Pres Global Brands & Inno

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,325 shares

Expires 2023-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F4 · derivative.exercise_price: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F4 · shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F5 · derivative.exercise_date: Stock options are fully vested and exerciseable.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:46 UTC
PALMER ANTHONY J.Pres Global Brands & Inno
SaleCommon Stock 36,320 $131.67 $4,782,254.40
Disclosure

SEC source: 0001225208-17-004176 · doc4.xml · nonDerivative · entry 2

PALMER ANTHONY J. · CIK 0001430476 · Pres Global Brands & Inno

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $131.67 to $131.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:46 UTC
PALMER ANTHONY J.Pres Global Brands & Inno
Exercise / conversionCommon Stock 30,325 $98.92 $2,999,873.33
Disclosure

SEC source: 0001225208-17-004176 · doc4.xml · nonDerivative · entry 1

PALMER ANTHONY J. · CIK 0001430476 · Pres Global Brands & Inno

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,320

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:45 UTC
Mielke Thomas J.SVP - General Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 8,894 $0.00 Strike: $75.22 $0.00
Disclosure

SEC source: 0001225208-17-004175 · doc4.xml · derivative · entry 6

Mielke Thomas J. · CIK 0001412476 · SVP - General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,894 shares

Expires 2022-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F4 · derivative.exercise_price: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F4 · shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F6 · derivative.exercise_date: Stock options are fully vested and exercisable.

F4 · derivative.underlying_shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:45 UTC
Mielke Thomas J.SVP - General Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 9,314 $0.00 Strike: $110.72 $0.00
Disclosure

SEC source: 0001225208-17-004175 · doc4.xml · derivative · entry 5

Mielke Thomas J. · CIK 0001412476 · SVP - General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,733

Underlying: Common Stock · 9,314 shares

Expires 2025-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F4 · derivative.exercise_price: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F4 · shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F5 · derivative.exercise_date: The option vests in three annual installments of 30%, 30% and 40%, beginning on April 29, 2016.

F4 · derivative.underlying_shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:45 UTC
Mielke Thomas J.SVP - General Counsel
SaleCommon Stock 18,208 $131.53 $2,394,898.24
Disclosure

SEC source: 0001225208-17-004175 · doc4.xml · nonDerivative · entry 3

Mielke Thomas J. · CIK 0001412476 · SVP - General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,144.7263

F1 · price: This transaction was executed in multiple trades at prices ranging from $131.50 to $131.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:45 UTC
Mielke Thomas J.SVP - General Counsel
Exercise / conversionCommon Stock 8,894 $75.22 $669,009.35
Disclosure

SEC source: 0001225208-17-004175 · doc4.xml · nonDerivative · entry 2

Mielke Thomas J. · CIK 0001412476 · SVP - General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,352.7263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:45 UTC
Mielke Thomas J.SVP - General Counsel
Exercise / conversionCommon Stock 9,314 $110.72 $1,031,246.08
Disclosure

SEC source: 0001225208-17-004175 · doc4.xml · nonDerivative · entry 1

Mielke Thomas J. · CIK 0001412476 · SVP - General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,458.7263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:44 UTC
FALK THOMAS JDirector · Chairman of the Board and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 60,964 $0.00 Strike: $110.72 $0.00
Disclosure

SEC source: 0001225208-17-004174 · doc4.xml · derivative · entry 6

FALK THOMAS J · CIK 0001222890 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,251

Underlying: Common Stock · 60,964 shares

Expires 2025-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.

F6 · derivative.exercise_price: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F6 · shares: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

F7 · derivative.exercise_date: The option vests in three annual installments of 30%, 30% and 40%, beginning on April 29, 2016.

F6 · balance_after: All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:44 UTC
FALK THOMAS JDirector · Chairman of the Board and CEO
SaleCommon Stock 60,964 $131.61 $8,023,472.04
Disclosure

SEC source: 0001225208-17-004174 · doc4.xml · nonDerivative · entry 2

FALK THOMAS J · CIK 0001222890 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $131.21 to $132.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2017 Filed Feb 22, 2017 22:44 UTC
FALK THOMAS JDirector · Chairman of the Board and CEO
Exercise / conversionCommon Stock 60,964 $110.72 $6,749,934.08
Disclosure

SEC source: 0001225208-17-004174 · doc4.xml · nonDerivative · entry 1

FALK THOMAS J · CIK 0001222890 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2017 Filed Feb 2, 2017 21:59 UTC
Underhill Kimberly KPresident, KCP
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-002270 · doc4.xml · nonDerivative · entry 2

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,787

Read SEC document
February 01, 2017 Filed Feb 2, 2017 21:59 UTC
Underhill Kimberly KPresident, KCP
SaleCommon Stock 4,000 $120.95 $483,800.00
Disclosure

SEC source: 0001225208-17-002270 · doc4.xml · nonDerivative · entry 1

Underhill Kimberly K · CIK 0001601970 · President, KCP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,912

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:51 UTC GrantRestricted Share Units · Derivative 5.8664 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-17-000795 · doc4.xml · derivative · entry 2

Quarles Christa S · CIK 0001677329 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,311.3178

Underlying: Common Stock · 5.8664 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:51 UTC
PALMER ANTHONY J.Pres Global Brands & Inno
GrantRestricted Share Units 02/29/2016 (w/dividends reinvested) · Derivative 46.9436 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-17-000794 · doc4.xml · derivative · entry 1

PALMER ANTHONY J. · CIK 0001430476 · Pres Global Brands & Inno

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,924.0782

Underlying: Common Stock · 46.9436 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock.

F1 · price: Represents restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock.

F2 · derivative.exercise_date: The restricted share units will vest on 02/28/2019.

F2 · derivative.expiration_date: The restricted share units will vest on 02/28/2019.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:51 UTC
MacQuillan SandraSVP Chief Supply Chain Officer
GrantRestricted Share Units 04/29/2015 (w/dividends reinvested) · Derivative 102.5007 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-17-000793 · doc4.xml · derivative · entry 1

MacQuillan Sandra · CIK 0001640668 · SVP Chief Supply Chain Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,935.139

Underlying: Common Stock · 102.5007 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock.

F1 · price: Represents restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock.

F2 · derivative.exercise_date: The restricted share units will vest in one-fifth increments on each of the first through fifth anniversaries of the grant date.

F2 · derivative.expiration_date: The restricted share units will vest in one-fifth increments on each of the first through fifth anniversaries of the grant date.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:51 UTC GrantRestricted Share Units · Derivative 15.0218 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-000792 · doc4.xml · derivative · entry 2

WHITE MICHAEL D · CIK 0001219007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,466.6853

Underlying: Common Stock · 15.0218 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:50 UTC GrantRestricted Share Units · Derivative 311.9066 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-000791 · doc4.xml · derivative · entry 2

SHAPIRO MARC J · CIK 0001179585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,932.248

Underlying: Common Stock · 311.9066 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:50 UTC GrantRestricted Share Units · Derivative 108.6512 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-000789 · doc4.xml · derivative · entry 2

KARCH NANCY J · CIK 0001197174 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,457.299

Underlying: Common Stock · 108.6512 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:50 UTC
READ IAN CDirector
GrantRestricted Share Units · Derivative 181.9462 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-000790 · doc4.xml · derivative · entry 2

READ IAN C · CIK 0001372915 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,706.8177

Underlying: Common Stock · 181.9462 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:50 UTC GrantRestricted Share Units · Derivative 210.4635 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-000788 · doc4.xml · derivative · entry 2

JENNESS JAMES M · CIK 0001188369 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,392.5964

Underlying: Common Stock · 210.4635 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:50 UTC
JEMISON MAEDirector
GrantRestricted Share Units · Derivative 277.899 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-000787 · doc4.xml · derivative · entry 2

JEMISON MAE · CIK 0001216571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,640.6301

Underlying: Common Stock · 277.899 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document
January 04, 2017 Filed Jan 5, 2017 22:50 UTC GrantRestricted Share Units · Derivative 78.1467 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-17-000786 · doc4.xml · derivative · entry 2

GARCIA FABIAN T · CIK 0001219440 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,432.7634

Underlying: Common Stock · 78.1467 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.